(5S)-3-[(2R)-2-(tert-butyldimethylsilyloxy)-8,9-epoxynonan-1-yl]-5-methyl-3,4-dihydrofuran-2-one | 1011733-91-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (5S)-3-[(2R)-2-(tert-butyldimethylsilyloxy)-8,9-epoxynonan-1-yl]-5-methyl-3,4-dihydrofuran-2-one
• 英文别名: (2S)-4-[(2R)-2-[tert-butyl(dimethyl)silyl]oxy-7-(oxiran-2-yl)heptyl]-2-methyl-2H-furan-5-one
• CAS: 1011733-91-7
• 化学式: C₂₀H₃₆O₄Si
• 分子量: 368.589
• InChiKey: OEWDOGPFDMWWAL-CTDRKSARSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.99
• 重原子数：
  25
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  48.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (5S)-3-[(2R)-2-(tert-butyldimethylsilyloxy)-8,9-epoxynonan-1-yl]-5-methyl-3,4-dihydrofuran-2-one 在 水 、 溶剂黄146 作用下， 以 四氢呋喃 为溶剂， 反应 24.0h， 以43%的产率得到(5S)-3-[(2R,8R)-2-(tert-butyldimethylsilyloxy)-8,9-epoxynonan-1-yl]-5-methyl-3,4-dihydrofuran-2-one
  参考文献：
  名称：

  Synthesis of pyranicin and its deoxygenated analogues and their inhibitory action with bovine heart mitochondrial complex I

  摘要：

  Total synthesis of pyranicin and its deoxygenated analogues was achieved using Cl(2)Pd(CH(3)CN)(2) catalyzed diastereoselective cyclization of the allylic ester as the key step. The inhibitory activity of these compounds for mitochondrial NADH-ubiquinone oxicloreductase (complex I) was poorer than those of ordinary mono-THF acetogenins such as annonacin. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2008.06.028
• 作为产物：
  描述：

  (2S)-4-[(2R)-2-[tert-butyl(dimethyl)silyl]oxynon-8-enyl]-2-methyl-2H-furan-5-one 在 碳酸氢钠 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 反应 17.0h， 以87%的产率得到(5S)-3-[(2R)-2-(tert-butyldimethylsilyloxy)-8,9-epoxynonan-1-yl]-5-methyl-3,4-dihydrofuran-2-one
  参考文献：
  名称：

  Synthesis of pyranicin and its deoxygenated analogues and their inhibitory action with bovine heart mitochondrial complex I

  摘要：

  Total synthesis of pyranicin and its deoxygenated analogues was achieved using Cl(2)Pd(CH(3)CN)(2) catalyzed diastereoselective cyclization of the allylic ester as the key step. The inhibitory activity of these compounds for mitochondrial NADH-ubiquinone oxicloreductase (complex I) was poorer than those of ordinary mono-THF acetogenins such as annonacin. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2008.06.028

文献信息

• Synthesis of Pyranicin and Its Inhibitory Action with Bovine Heart Mitochondrial Complex I
  作者：Yasunao Hattori、Shin-ichi Furuhata、Motonori Okajima、Hiroyuki Konno、Masato Abe、Hideto Miyoshi、Tetsuhisa Goto、Hidefumi Makabe

  DOI：10.1021/ol702902w

  日期：2008.3.1

  Total synthesis of pyranicin was achieved using Cl2Pd(CH3CN)(2)-catalyzed diastereoselective cyclization of the allylic ester as the key step. The inhibitory activity of this compound for mitochondrial NADH-ubiquinone oxidoreductase (complex I) was slightly poorer than that of ordinary mono-THF acetogenins such as cis-solamin.
• Synthesis of pyranicin and its deoxygenated analogues and their inhibitory action with bovine heart mitochondrial complex I
  作者：Shin-ichi Furuhata、Yasunao Hattori、Motonori Okajima、Hiroyuki Konno、Masato Abe、Hideto Miyoshi、Tetsuhisa Goto、Hidefumi Makabe

  DOI：10.1016/j.tet.2008.06.028

  日期：2008.8

  Total synthesis of pyranicin and its deoxygenated analogues was achieved using Cl(2)Pd(CH(3)CN)(2) catalyzed diastereoselective cyclization of the allylic ester as the key step. The inhibitory activity of these compounds for mitochondrial NADH-ubiquinone oxicloreductase (complex I) was poorer than those of ordinary mono-THF acetogenins such as annonacin. (C) 2008 Elsevier Ltd. All rights reserved.